ATI-5923

ATI-5923 · ARYx Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATI-5923, covering 2010-02-02 to 2010-02-02. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation [Phase 2, Phase 3]

See pricing